Microbix Biosystms (TSE:MBX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Microbix Biosystems has teamed up with EMQN to launch a novel genetic-test program aimed at identifying patients susceptible to antibiotic-induced hearing loss. This initiative, which utilizes Microbix’s quality assessment products, is crucial for ensuring accurate diagnoses and effective treatment plans, particularly for newborns at risk of severe infections.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
